These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19950331)

  • 1. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
    Bannan A; Shen R; Silvestry FE; Herrmann HC
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1066-9. PubMed ID: 19670302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another addition to the tool box.
    Tuzcu EM
    Catheter Cardiovasc Interv; 2008 May; 71(6):829-30. PubMed ID: 18412080
    [No Abstract]   [Full Text] [Related]  

  • 5. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closure of patent foramen ovale: The abolition of stroke and asymptotic realities.
    Tan WA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):517-8. PubMed ID: 15274164
    [No Abstract]   [Full Text] [Related]  

  • 7. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 8. New aspects of paradoxical embolism.
    Lehmeyer S; Lindhoff-Last E
    Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic significant patent foramen ovale: giving patent foramen ovale management back to the cardiologist.
    Rigatelli G; Cardaioli P; Chinaglia M
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):573-7. PubMed ID: 18307240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
    Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Transcatheter Closure of Patent Foramen Ovale.
    Neill J; Lin CH
    Methodist Debakey Cardiovasc J; 2017; 13(3):152-159. PubMed ID: 29744000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
    Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX
    J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
    Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue treatment by percutaneous closure of interatrial septal defect or PFO in infants with Berlin heart.
    Gagliardi MG; Papavasileiou L; Pongiglione G
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):577-9. PubMed ID: 20853353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptogenic stroke patients with patent foramen ovale should be closed only in the setting of a randomized control trial.
    Felberg RA
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):4-5. PubMed ID: 17173277
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
    Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
    [No Abstract]   [Full Text] [Related]  

  • 18. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes.
    Staubach S; Bertog S; Wunderlich N; Sievert H
    Future Cardiol; 2009 Sep; 5(5):503-10. PubMed ID: 19715414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 20. PFO and paradoxical embolism producing events other than stroke.
    Dao CN; Tobis JM
    Catheter Cardiovasc Interv; 2011 May; 77(6):903-9. PubMed ID: 21207422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.